Other Species / Isoforms
  RPS17 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K19-ac
AARVIIEkYyTrLGN
0 17
RPS17 (human) AARVIIEkYyTrLGN K19-ac
RPS17 (mouse) AARVIIEkYyTRLGN K19-ac
RPS17 (rat) AARVIIEkYYTRLGN K19-ac
K19-ub
AARVIIEkYyTrLGN
0 80
RPS17 (human) AARVIIEkYyTrLGN K19-ub
RPS17 (mouse) AARVIIEkYyTRLGN K19-ub
RPS17 (rat) AARVIIEKYYTRLGN K19
K19-sc
AARVIIEkYyTrLGN
0 1
RPS17 (human) AARVIIEkYyTrLGN K19-sc
RPS17 (mouse) AARVIIEkYyTRLGN K19-sc
RPS17 (rat) AARVIIEKYYTRLGN K19
Y21-p
RVIIEkYyTrLGNDF
0 7
RPS17 (human) RVIIEkYyTrLGNDF Y21-p
RPS17 (mouse) RVIIEkYyTRLGNDF Y21-p
RPS17 (rat) RVIIEkYYTRLGNDF Y21
R23-m1
IIEkYyTrLGNDFHT
0 1
RPS17 (human) IIEkYyTrLGNDFHT R23-m1
RPS17 (mouse) IIEkYyTRLGNDFHT R23
RPS17 (rat) IIEkYYTRLGNDFHT R23
K32-ac
GNDFHTNkRVCEEIA
0 5
RPS17 (human) GNDFHTNkRVCEEIA K32-ac
RPS17 (mouse) GNDFHTNKRVCEEIA K32
RPS17 (rat) GNDFHTNKRVCEEIA K32
K32-ub
GNDFHTNkRVCEEIA
0 8
RPS17 (human) GNDFHTNkRVCEEIA K32-ub
RPS17 (mouse) GNDFHTNKRVCEEIA K32
RPS17 (rat) GNDFHTNKRVCEEIA K32
K44-ub
EIAIIPSkKLRNkIA
0 3
RPS17 (human) EIAIIPSkKLRNkIA K44-ub
RPS17 (mouse) EIAIIPSKKLRNkIA K44
RPS17 (rat) EIAIIPSKNLRNKIA K44
K49-ub
PSkKLRNkIAGyVtH
0 31
RPS17 (human) PSkKLRNkIAGyVtH K49-ub
RPS17 (mouse) PSKKLRNkIAGyVTH K49-ub
RPS17 (rat) PSKNLRNKIAGYVTH K49
K49-ac
PSkKLRNkIAGyVtH
0 1
RPS17 (human) PSkKLRNkIAGyVtH K49-ac
RPS17 (mouse) PSKKLRNKIAGyVTH K49
RPS17 (rat) PSKNLRNKIAGYVTH K49
Y53-p
LRNkIAGyVtHLMkR
0 12
RPS17 (human) LRNkIAGyVtHLMkR Y53-p
RPS17 (mouse) LRNkIAGyVTHLMKR Y53-p
RPS17 (rat) LRNKIAGYVTHLMkR Y53
T55-p
NkIAGyVtHLMkRIQ
0 1
RPS17 (human) NkIAGyVtHLMkRIQ T55-p
RPS17 (mouse) NkIAGyVTHLMKRIQ T55
RPS17 (rat) NKIAGYVTHLMkRIQ T55
K59
GyVtHLMKRIQRGPV
0 1
RPS17 (human) GyVtHLMKRIQRGPV K59
RPS17 (mouse) GyVTHLMKRIQRGPV K59
RPS17 (rat) GYVTHLMkRIQRGPV K59-ac
K59-ub
GyVtHLMkRIQRGPV
0 5
RPS17 (human) GyVtHLMkRIQRGPV K59-ub
RPS17 (mouse) GyVTHLMKRIQRGPV K59
RPS17 (rat) GYVTHLMKRIQRGPV K59
S70-p
RGPVRGIsIkLQEEE
0 1
RPS17 (human) RGPVRGIsIkLQEEE S70-p
RPS17 (mouse) RGPVRGISIkLQEEE S70
RPS17 (rat) RGPVRGISIKLQEEE S70
K72-ub
PVRGIsIkLQEEERE
0 11
RPS17 (human) PVRGIsIkLQEEERE K72-ub
RPS17 (mouse) PVRGISIkLQEEERE K72-ub
RPS17 (rat) PVRGISIKLQEEERE K72
K72-ac
PVRGIsIkLQEEERE
0 1
RPS17 (human) PVRGIsIkLQEEERE K72-ac
RPS17 (mouse) PVRGISIKLQEEERE K72
RPS17 (rat) PVRGISIKLQEEERE K72
Y84-p
ERERRDNyVPEVsAL
0 1
RPS17 (human) ERERRDNyVPEVsAL Y84-p
RPS17 (mouse) ERERRDNYVPEVSAL Y84
RPS17 (rat) ERERRDNYVPEVSAL Y84
S89-p
DNyVPEVsALDQEII
0 1
RPS17 (human) DNyVPEVsALDQEII S89-p
RPS17 (mouse) DNYVPEVSALDQEII S89
RPS17 (rat) DNYVPEVSALDQEII S89
T102-p
IIEVDPDtkEMLkLL
0 2
RPS17 (human) IIEVDPDtkEMLkLL T102-p
RPS17 (mouse) IIEVDPDtkEMLkLL T102-p
RPS17 (rat) IIEVDPDTKEMLKLL T102
K103-ac
IEVDPDtkEMLkLLD
0 1
RPS17 (human) IEVDPDtkEMLkLLD K103-ac
RPS17 (mouse) IEVDPDtkEMLkLLD K103-ac
RPS17 (rat) IEVDPDTKEMLKLLD K103
K103-ub
IEVDPDtkEMLkLLD
0 12
RPS17 (human) IEVDPDtkEMLkLLD K103-ub
RPS17 (mouse) IEVDPDtkEMLkLLD K103-ub
RPS17 (rat) IEVDPDTKEMLKLLD K103
K103-sm
IEVDPDtkEMLkLLD
0 3
RPS17 (human) IEVDPDtkEMLkLLD K103-sm
RPS17 (mouse) IEVDPDtKEMLkLLD K103
RPS17 (rat) IEVDPDTKEMLKLLD K103
K103
IEVDPDtKEMLkLLD
0 1
RPS17 (human) IEVDPDtKEMLkLLD K103
RPS17 (mouse) IEVDPDtkEMLkLLD K103-sc
RPS17 (rat) IEVDPDTKEMLKLLD K103
K107
PDtkEMLKLLDFGsL
0 1
RPS17 (human) PDtkEMLKLLDFGsL K107
RPS17 (mouse) PDtkEMLkLLDFGsL K107-ac
RPS17 (rat) PDTKEMLKLLDFGsL K107
K107-ub
PDtkEMLkLLDFGsL
Upstream
0 85
Treatment
  • MG132
RPS17 (human) PDtkEMLkLLDFGsL K107-ub
RPS17 (mouse) PDtkEMLkLLDFGsL K107-ub
RPS17 (rat) PDTKEMLKLLDFGsL K107
S113-p
LkLLDFGsLsNLQVt
Upstream
0 78
Treatment
  • anti-CD3
RPS17 (human) LkLLDFGsLsNLQVt S113-p
RPS17 (mouse) LkLLDFGsLsNLQVT S113-p
RPS17 (rat) LKLLDFGsLSNLQVT S113-p
S115-p
LLDFGsLsNLQVtQP
0 21
RPS17 (human) LLDFGsLsNLQVtQP S115-p
RPS17 (mouse) LLDFGsLsNLQVTQP S115-p
RPS17 (rat) LLDFGsLSNLQVTQP S115
T120-p
sLsNLQVtQPtVGMN
0 1
RPS17 (human) sLsNLQVtQPtVGMN T120-p
RPS17 (mouse) sLsNLQVTQPTVGMN T120
RPS17 (rat) sLSNLQVTQPTVGMN T120
T123-p
NLQVtQPtVGMNFkt
0 4
RPS17 (human) NLQVtQPtVGMNFkt T123-p
RPS17 (mouse) NLQVTQPTVGMNFkt T123
RPS17 (rat) NLQVTQPTVGMNFKT T123
K129-ac
PtVGMNFktPRGPV_
0 5
RPS17 (human) PtVGMNFktPRGPV_ K129-ac
RPS17 (mouse) PTVGMNFKtPRGAV_ K129
RPS17 (rat) PTVGMNFKTPRGAV_ K129
K129-m1
PtVGMNFktPRGPV_
0 1
RPS17 (human) PtVGMNFktPRGPV_ K129-m1
RPS17 (mouse) PTVGMNFKtPRGAV_ K129
RPS17 (rat) PTVGMNFKTPRGAV_ K129
K129-ub
PtVGMNFktPRGPV_
0 41
RPS17 (human) PtVGMNFktPRGPV_ K129-ub
RPS17 (mouse) PTVGMNFktPRGAV_ K129-ub
RPS17 (rat) PTVGMNFKTPRGAV_ K129
T130-p
tVGMNFktPRGPV__
Upstream
0 40
Treatment
  • nocodazole
RPS17 (human) tVGMNFktPRGPV__ T130-p
RPS17 (mouse) TVGMNFktPRGAV__ T130-p
RPS17 (rat) TVGMNFKTPRGAV__ T130